Molecular Pathogenesis and New Interventions in Scleroderma: Request for Applications (RFA)

The goal of this Request for Applications is to foster the development of research that will advance our understanding of the pathogenesis of scleroderma and to promote the design, development, and pilot testing of hypothesis-driven, innovative therapeutic approaches.

This RFA offers three mechanisms of support:

Investigator-Initiated Research Grant (SRF01)

 larger-scale project in scleroderma research

Funding: $200,000 per year 

Duration: 3 years

Exploratory/Developmental Research Grant (SRF02)

Cross-disciplinary approach toward scleroderma research in a smaller-scale projects

Funding: $75,000 per year 

Duration: 2 year

New Faculty Grant (SRF03):

Candidate should be within seven years of receipt of her/his research or health professional doctoral degree as of the date of application.

Funding: $75,000 per year 

Duration:2 year

Research Authority due date: 10.2.25